Skip to main content
. 2022 Nov 24;28(12):2547–2554. doi: 10.1038/s41591-022-02075-9

Table 1.

Demographics and brain MTBR-tau measures of participants in the primary tauopathy cohort

Group Normal control FTLD-TDP PiD AGD PSP CBD AD FTLD-MAPT Total
n 3 12 3 1 16 12 7 8 62
Pure pathology N/A 5 3 0 9 7 7 6 37
Copathology (n) N/A AD (1), AGD (1), HS + vascular (1), MND (4) N/A Vascular (1) AD (4), LBD (2), vascular (1) AD (3), PSP (1), LBD (1) N/A AD (1), HS (1) 22
Age at death, years 81 ± 5 68 ± 11 70 ± 3 68 76 ± 7 69 ± 8 61 ± 6 63 ± 11 69 ± 10
Sex, M/F 1/2 8/4 1/2 1/0 6/10 5/7 4/3 5/3 31/31
Brain region (SFG/insula) 1/2 12/0 3/0 1/0 16/0 12/0 7/0 2/6 54/8
Brain MTBR-tau275/t-tau, SD 0.235 ± 0.053 0.213 ± 0.066 0.226 ± 0.110 0.200 0.489 ± 0.229 1.078 ± 0.346 0.319 ± 0.047 0.762 ± 0.333 0.536 ± 0.388
Brain MTBR-tau282/t-tau, SD 0.382 ± 0.097 0.348 ± 0.133 0.327 ± 0.151 0.294 0.789 ± 0.368 1.736 ± 0.760 0.915 ± 0.180 1.128 ± 0.512 0.895 ± 0.646

HS, hippocampal sclerosis; LBD, Lewy body dementia; MND, motor neuron disease.